Epigenetic regulation of angiotensin-converting enzyme 2 (ACE2) by SIRT1 under conditions of cell energy stress

Clinical Science

Volumn 126, Issue 7, 2014, Pages 507-516

  Clarke, Nicola E ^a   Belyaev, Nikolai D ^a   Lambert, Daniel W ^b   Turner, Anthony J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

AMP activated protein kinase (AMPK); angiotensin (1 7); Angiotensin converting enzyme (ACE); angiotensin converting enzyme 2 (ACE2); renin angiotensin system; Sirt1

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ANGIOTENSIN CONVERTING ENZYME 2; INTERLEUKIN 1BETA; METFORMIN; SILENT INFORMATION REGULATOR PROTEIN; SILENT INFORMATION REGULATOR T1; UNCLASSIFIED DRUG;

ARTICLE; CELL ENERGY; CELL STRESS; CONTROLLED STUDY; DOWN REGULATION; EPIGENETICS; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 84891387188     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20130291     Document Type: Article

References (63)

1. Mehta, P. K. and Griendling, K. K. (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am. J. Physiol. Cell Physiol. 292, C82-C97
2. Passos-Silva, D. G., Verano-Braga, T. and Santos, R. A. (2013) Angiotensin-(1-7): beyond the cardio-renal actions. Clin. Sci. 124, 443-456
3. Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G. and Turner, A. J. (2000) A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captoprilinsensitive carboxypeptidase. J. Biol. Chem. 275, 33238-33243
4. Clarke, N. E. and Turner, A. J. (2012) Angiotensin-converting enzyme 2: the first decade. Int. J. Hypertens. 2012, 307315
5. Kuba, K., Imai, Y. and Penninger, J. M. (2013) Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases. Circ. J. 77, 301-308
6. Clarke, N. E., Fisher, M. J., Porter, K. E., Lambert, D. W. and Turner, A. J. (2012) Angiotensin converting enzyme (ACE) and ACE2 bind integrins and ACE2 regulates integrin signalling. PLoS ONE 7, 34747
7. Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C. et al. (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450-454
8. Tan, Z., Wu, J. and Ma, H. (2011) Regulation of angiotensin-converting enzyme 2 and Mas receptor by Ang-(1-7) in heart and kidney of spontaneously hypertensive rats. JRAAS 12, 413-419
9. Kuan, T. C., Yang, T. H., Wen, C. H., Chen, M. Y., Lee, I. L. and Lin, C. S. (2011) Identifying the regulatory element for human angiotensin-converting enzyme 2 (ACE2) expression in human cardiofibroblasts. Peptides 32, 1832-1839
10. Koka, V., Huang, X. R., Chung, A. C., Wang, W., Truong, L. D. and Lan, H. Y. (2008) Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway. Am. J. Pathol. 172, 1174-1183
11. Gallagher, P. E., Chappell, M. C., Ferrario, C. M. and Tallant, E. A. (2006) Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes. Am. J. Physiol. Cell Physiol. 290, C420-C426
12. Meduri, G. U., Headley, S., Kohler, G., Stentz, F., Tolley, E., Umberger, R. and Leeper, K. (1995) Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1β and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 107, 1062-1073
13. Sharma, V., Sudipta, S. K., Dixit, D. and SenN, E. (2012) Farnesyltransferase inhibitor manumycin targets IL1β-Ras-HIF-1α axis in tumor cells of diverse origin. Inflammation 35, 516-519
14. Zhang, R., Wu, Y., Zhao, M., Liu, C., Zhou, L., Shen, S., Liao, S., Yang, K., Li, Q. and Wan, H. (2009) Role of HIF-1α in the regulation ACE and ACE2 expression in hypoxic human pulmonary artery smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 297, L631-L640
15. Lambert, D. W., Yarski, M., Warner, F. J., Thornhill, P., Parkin, E. T., Smith, A. I., Hooper, N. M. and Turner, A. J. (2005) Tumor necrosis factor-α convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J. Biol. Chem. 280, 30113-30119
16. Tseng, Y. W., Wang, P. H., Lee, H. S., Liu, B. H., Mersmann, H. J., Lin, E. C. and Ding, S. T. (2010) Regulation of the expression of angiotensin-converting enzyme 2 by polyunsaturated fatty acids in porcine adipocytes. J. Anim. Sci. 88, 3563-3567
17. Ye, M., Wysocki, J., William, J., Soler, M. J., Cokic, I. and Batlle, D. (2006) Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes. J. Am. Soc. Nephrol. 17, 3067-3075
18. Kim, J. A., Jang, H. J., Martinez-Lemus, L. A. and Sowers, J. R. (2011) Activation of mTOR/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation. Am. J. Physiol. Endocrinol. Metab. 302, E201-E208
19. Chai, W., Wang, W., Dong, Z., Cao, W. and Liu, Z. (2011) Angiotensin II receptors modulate muscle microvascular and metabolic responses to insulin in vivo. Diabetes 60, 2939-2946
20. Hardie, D. G., Ross, F. A. and Hawley, S. A. (2012) AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13, 251-262
21. Tomas, E., Lin, Y. S., Dagher, Z., Saha, A., Luo, Z., Ido, Y. and Ruderman, N. B. (2002) Hyperglycemia and insulin resistance: possible mechanisms. Ann. N.Y. Acad. Sci. 967, 43-51
22. Nadtochiy, S. M., Yao, H., McBurney, M. W., Gu, W., Guarente, L., Rahman, I. and Brookes, P. S. (2011) SIRT1-mediated acute cardioprotection. Am. J. Physiol. Heart Circ. Physiol. 301, H1506-H1512
23. Lan, F., Cacicedo, J. M., Ruderman, N. and Ido, Y. (2008) SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J. Biol. Chem. 283, 27628-27635
24. Ruderman, N. B., Xu, X. J., Nelson, L., Cacicedo, J. M., Saha, A. K., Lan, F. and Ido, Y. (2012) AMPK and SIRT1: a long-standing partnership? Am. J. Physiol. Endocrinol. Metab. 298, E751-E760
25. Brachmann, C. B., Sherman, J. M., Devine, S. E., Cameron, E. E., Pillus, L. and Boeke, J. D. (1995) The SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability. Genes Dev. 9, 2888-2902
26. Guarente, L. (2000) Sir2 links chromatin silencing, metabolism, and aging. Genes Dev. 14, 1021-1026
27. Sunderasan, N. R., Pillai, V. B. and Gupta, M. P. (2011) Emerging roles of SIRT1 deacetylase in regulating cardiomyocyte survival and hypertrophy. J. Mol. Cell. Cardiol. 51, 614-618
28. Jung, T. W., Lee, K.-T., Lee, M. W. and Ka, K.-H. (2012) SIRT1 attenuates palmitate-induced endoplasmic reticulum stress and insulin resistance in HepG2 cells via induction of oxygenregulated protein 150. Biochem. Biophys. Res. Commun. 422, 229-232
29. Hao, C. M. and Haase, V. H. (2010) Sirtuins and their relevance to the kidney. J. Am. Soc. Nephrol. 21, 1620-1627
30. Mores, A., Matziari, M., Beau, F., Cuniasse, P., Yiotakis, A. and Dive, V. (2008) Development of potent and selective phosphinic peptide inhibitors of angiotensin-converting enzyme 2. J. Med. Chem. 51, 2216-2226
31. Napper, A. D., Hixon, J., McDonagh, T., Keavey, K., Pons, J. F., Barker, J., Yau, W. T., Amouzegh, P., Flegg, A., Hamelin, E. et al. (2005) Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1. J. Med. Chem. 48, 8045-8054
32. Lambert, D. W., Clarke, N. E., Hooper, N. M. and Turner, A. J. (2008) Calmodulin interacts with angiotensin-converting enzyme-2 (ACE2) and inhibits shedding of its ectodomain. FEBS Lett. 582, 385-390
33. Belyaev, N. D., Nalivaeva, N. N., Makova, N. Z. and Turner, A. J. (2009) Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease. EMBO Rep. 10, 94-100
34. Terai, K., Hiramoto, Y., Masaki, M., Sugiyama, S., Kuroda, T., Hori, M., Kawase, I. and Hirota, H. (2005) AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress. Mol. Cell. Biol. 25, 9554-9575
35. Boyle, J. G., Salt, I. P. and McKay, G. A. (2010) Metformin action on AMP-activated protein kinase: a translational research approach to understanding a potential new therapeutic target. Diabet. Med. 27, 1097-1106
36. Rosenbloom, K. R., Dreszer, T. R., Pheasant, M., Barber, G. P., Meyer, L. R., Pohl, A., Raney, B. J., Wang, T., Hinrichs, A. S., Zweig, A. S. et al. (2010) ENCODE whole-genome data in the UCSC Genome Browser. Nucleic Acids Res. 38, D620-D625
37. Goulter, A. B., Goddard, M. J., Allen, J. C. and Clark, K. L. (2004) ACE2 gene expression is up-regulated in the human failing heart. BMC Med. 2, 19
38. Kar, S., Gao, L. and Zucker, I. H. (2010) Exercise training normalizes ACE and ACE2 in the brain of rabbits with pacing-induced heart failure. J. Appl. Physiol. 108, 923-932
39. Zhang, C., Zhao, Y. X., Zhang, Y. H., Zhu, L., Deng, B. P., Zhou, Z. L., Li, S. Y., Lu, X. T., Song, L. L., Lei, X. M. et al. (2010) Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells. Proc. Natl. Acad. Sci. U.S.A. 107, 15886-15891
40. Gupte, M., Boustany-Kari, C. M., Bharadwaj, K., Police, S., Thatcher, S., Gong, M. C., English, V. L. and Cassis, L. A. (2008) ACE2 is expressed in adipocytes and regulated by a high fat diet. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R781-R788
41. Hashimoto, T., Perlot, T., Rehman, A., Trichereau, J., Ishiguro, H., Paolino, M., Sigl, V., Hanada, T., Hanada, R., Lipinski, S. et al. (2012) ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 487, 477-481
42. Kassiri, Z., Zhong, J., Guo, D., Basu, R., Wang, X., Liu, P. P., Scholey, J. W., Penninger, J. M. and Oudit, G. Y. (2009) Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction. Circ. Heart Fail. 2, 446-455
43. Ocaranza, M. P., Godoy, I., Jalil, J. E., Varas, M., Collantes, P., Pinto, M., Roman, M., Ramirez, C., Copaja, M., Diaz-Araya, G. et al. (2006) Enalapril attenuates downregulation of angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat. Hypertension 48, 572-578
44. Paizis, G., Tikellis, C., Cooper, M. E., Schembri, J. M., Lew, R. A., Smith, A. I., Shaw, T., Warner, F. J., Zuilli, A. and Burrell, L. M. (2005) Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 54, 1790-1796
45. Moon, J. Y., Tanimoto, M., Gohda, T., Hagiwara, S., Yamazaki, T., Ohara, I., Murakoshi, M., Aoki, T., Ishikawa, Y., Lee, S. H. et al. (2011) Attenuating effect of angiotensin-(1-7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-Ay/Ta mice. Am. J. Physiol. Renal Physiol. 300, F1271-F1282
46. Soler, M. J., Wysocki, J., Ye, M., Lloveras, J., Kanwar, Y. and Battle, D. (2007) ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocininduced diabetic mice. Kidney Int. 72, 614-623
47. Kickstein, E., Krauss, S., Thornhill, P., Rutschow, D., Zeller, R., Sharkey, J., Williamson, R., Fuchs, M., Köhler, A., Glossmann, H. et al. (2010) Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling. Proc. Natl. Acad. Sci. U.S.A. 107, 21830-21835
48. Kalender, A., Selvaraj, A., Kim, S. Y., Gulati, P., Brûlé, S., Viollet, B., Kemp, B. E., Bardeesy, N., Dennis, P., Schlager, J. J. et al. (2010) Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Cell Metab. 11, 390-401
49. Ben Sahra, I., Regazzetti, C., Robert, G., Laurent, K., Le Marchand-Brustel, Y., Auberger, P., Tanti, J. F., Giorgetti-Peraldi, S. and Bost, F. (2011) Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1. Cancer Res. 71, 4366-4372
50. Musi, N., Hirshman, M. F., Nygren, J., Svanfeldt, M., Bavenholm, P., Rooyackers, O., Zhou, G., Williamson, J. M., Ljunqvist, O., Efendic, S. et al. (2002) Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 51, 2074-2081
51. Owen, M. R., Doran, E. and Halestrap, A. P. (2000) Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem. J. 348, 607-614
52. Hawley, S. A., Gadalla, A. E., Olsen, G. S. and Hardie, D. G. (2002) The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51, 2420-2425
53. Foretz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F. and Viollet, B. (2010) Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J. Clin. Invest. 120, 2355-2369
54. Perkins, G. D., Gao, F. and Thickett, D. R. (2008) In vivo and in vitro effects of salbutamol on alveolar epithelial repair in acute lung injury. Thorax 63, 215-220
55. Geiser, T., Atabai, K., Jarreau, P. H., Ware, L. B., Pugin, J. and Matthay, M. A. (2001) Pulmonary edema fluid from patients with acute lung injury augments in vitro alveolar epithelial repair by an IL-1β-dependent mechanism. Am. J. Respir. Crit. Care Med. 163, 1384-1388
56. Haschke, M., Schuster, M., Poglitsch, M., Loibner, H., Salzberg, M., Bruggisser, M., Penninger, J. and Krähenbühl, S. (2013) Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects. Clin. Pharmacokinet. 52, 783-792
57. Zhang, Z., Lowry, S. F., Guarente, L. and Haimovich, B. (2010) Roles of SIRT1 in the acute and restorative phases following induction of inflammation. J. Biol. Chem. 285, 41391-41401
58. Ajmo, J. M., Liang, X., Rogers, C. Q., Pennock, B. and You, M. (2008) Resveratrol alleviates alcoholic fatty liver in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 295, G833-G842
59. Gillum, M. P., Kotas, M. E., Erion, D. M., Kursawe, R., Chatterjee, P., Nead, K. T., Muise, E. S., Hsiao, J. J., Frederick, D. W., Yonemitsu, S. et al. (2011) SirT1 regulates adipose tissue inflammation. Diabetes 60, 3235-3245
60. Chalkiadaki, A. and Guarente, L. (2012) High-fat diet triggers inflammation-induced cleavage of SIRT1 in adipose tissue to promote metabolic dysfunction. Cell Metab. 16, 180-188
61. Altarejos, J. Y. and Montminy, M. (2011) CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat. Rev. Mol. Cell Biol. 12, 141-151
62. He, L., Sabet, A., Djedjos, S., Miller, R., Sun, X., Hussain, M. A., Radovick, S. and Wondisford, F. E. (2009) Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein. Cell 137, 635-646
63. Jeong, H., Cohen, D. E., Cui, L., Supinski, A., Savas, J. N., Mazzulli, J. R., Yates, III, J. R., Bordone, L., Guarente, L. and Krainc, D. (2011) Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway. Nat. Med. 18, 159-165